In our latest Let's Talk Future episode, Doron Barness, Senior Managing Director and Global Head of Equities Trading and Distribution at Oppenheimer, delves into market trends post-election and why the outlook for the end of 2024 remains strong. Doron points out that historically, the S&P 500 has seen an average increase of 3-5% following U.S. elections, with the exceptions being 2000 and 2008. Given the momentum we've seen this year, he's confident that this trend will continue into year-end. Listen to the full episode here: https://lnkd.in/eN4hYAgz #ThePowerofOppenheimerThinking
Oppenheimer & Co. Inc.
Financial Services
New York, NY 63,390 followers
Oppenheimer provides a full range of wealth management, securities brokerage, and investment banking services.
About us
Oppenheimer & Co. Inc. is a leading national investment boutique with over a century of tradition. Oppenheimer’s culture of providing innovative, customized solutions to our clients sets us apart from our competitors. Oppenheimer is proud of its reputation as a Firm that helps individuals, families, corporate executives, foundations and endowments, charities, pension plans businesses, and institutions. We occupy a unique position in the industry, thanks to the dedication, expertise, and creativity of our people. Oppenheimer Financial Advisors draw on the extensive resources and expertise of nearly 1,900 other professionals, including those in Equity Research, Capital Markets, and Investment Banking. Oppenheimer Asset Management Inc., Oppenheimer Life Agency Ltd., Oppenheimer Trust Company of Delaware and Oppenheimer & Co. Inc. are wholly owned subsidiaries of Oppenheimer Holdings Inc., an integrated financial holding company. Oppenheimer is a registered broker-dealer and investment advisory firm. Securities are offered through Oppenheimer.
- Website
-
http://www.oppenheimer.com
External link for Oppenheimer & Co. Inc.
- Industry
- Financial Services
- Company size
- 1,001-5,000 employees
- Headquarters
- New York, NY
- Type
- Public Company
- Founded
- 1881
- Specialties
- Wealth Management, Debt and Equity Capital Markets, Mergers & Acquisitions, Retirement Services, Asset Management, Investment Banking, and Equity Research
Locations
Employees at Oppenheimer & Co. Inc.
Updates
-
In our latest Let's Talk Future episode, Doron Barness, Senior Managing Director and Global Head of Equities Trading and Distribution at Oppenheimer, shares his outlook on the market heading into the end of 2024 and the transition into 2025. As we approach year-end, Doron highlights the solid performance across sectors and discusses why the market is positioned for continued strength. However, he also points to potential risks—such as a challenging start for quantitative strategies or underinvested mutual funds—that could cause volatility at the beginning of the new year. Listen to the full episode here: https://lnkd.in/eN4hYAgz #ThePowerofOppenheimerThinking
-
The votes are in, and the fixed income market is adapting to evolving expectations around interest rates, inflation, and government spending. In this article, the Oppenheimer Investment Advisors team shares their insights on the post-election fixed income landscape, highlighting their strategic approach to navigating emerging opportunities and managing risks in a dynamic environment. Read More: https://lnkd.in/eUWw7Q-4
-
-
Congratulations to The Summa Group for earning a spot on the prestigious Forbes SHOOK Research America’s Top 100 Wealth Management Teams Private Wealth 2024 list — ranking #57 nationwide and #15 in California! This incredible achievement reflects the team’s exceptional dedication, expertise, and commitment to delivering outstanding service to their clients. #ThePowerofOppenheimerThinking Awards Criteria: https://lnkd.in/ebBVetx5
-
-
With the Fed having begun the process of cutting its benchmark rate, equities appear well positioned to benefit as interest rates likely move somewhat if not much lower over the months ahead.
What’s Going On? | 11/18/2024 Market Strategy
oppenheimer.com
-
The Oppenheimer Women’s Network proudly hosted its inaugural Lunch & Learn, spotlighting three powerhouse leaders driving Oppenheimer’s Public Finance, Municipal Underwriting, and Municipal Sales departments: Elizabeth Coolidge, Beth Wolchock, and Cynthia Henry Pinto. Moderated by Madison Maher, the panel provided invaluable insights on career growth, balancing work and life, and leading with purpose. Thank you to everyone who joined us to learn from these inspiring leaders! #OWN #ThePowerofOppenheimerThinking
-
-
In our latest Let's Talk Future episode, Doron Barness, Senior Managing Director and Global Head of Equities Trading and Distribution at Oppenheimer, discusses how key catalysts shaped the markets this year. From strong earnings—especially in the banking sector—to the swift resolution of the election outcome, Doron highlights how these factors provided much-needed confidence and helped reduce market anxiety. Listen to the full episode here: https://lnkd.in/eN4hYAgz #ThePowerofOppenheimerThinking
-
Celebrating 20 years of powerful partnerships! Our Professionals Alliance Group (PAG) brought together financial advisors, CPAs, and other trusted advisors at our NYC headquarters to explore new ways of delivering client-focused solutions. This unique program empowers industry professionals to leverage Oppenheimer’s wealth management and investment banking expertise to better serve clients. Learn More 👉 https://lnkd.in/eA6UVkZY #OppenheimerPAG #ThePowerofOppenheimerThinking Glenn Evans, Mike Peloquin, CFP®, Ronald Stumpf, Yale A. Saltzman, CFA®, Peter Charles Palumbo, Craig Stemmermann, Jennifer Myers, Andrey Zahariev, Shannon Johnson, Sally Gendy
-
-
Oppenheimer is a proud sponsor of Biotech’s Next Challenge: Delivering on the Story. Join BioCentury Inc., BioIndustry Association (BIA), and industry leaders at the second annual CEO and investor dialogue, held on the sidelines of the Jefferies London Healthcare Conference. Our very own Michael Margolis will be speaking on the Pharma & Investor Roundtable: Delivering on the Biotech Story, where he'll discuss key insights and strategies shaping the future of biotech. #ThePowerofOppenheimerThinking
-